Infections and brain development

Obstetrical and Gynecological Survey

Volumn 70, Issue 10, 2015, Pages 644-655

  Cordeiro, Christina N ^a   Tsimis, Michael ^a   Burd, Irina ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

AUTISM; BACTERIAL INFECTION; BIPOLAR DISORDER; BRAIN CALCIFICATION; BRAIN DAMAGE; BRAIN DEVELOPMENT; BRAIN INJURY; CEREBRAL PALSY; CHORIOAMNIONITIS; CYTOKINE RESPONSE; FUNISITIS; GYNECOLOGIC INFECTION; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCEPHALUS; INFLAMMATION; INFLUENZA; META ANALYSIS (TOPIC); NONHUMAN; PARASITOSIS; PREGNANCY DISORDER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; SCHIZOPHRENIA; ANIMAL; BRAIN; BRAIN DISEASES; EMBRYOLOGY; FEMALE; FETUS DEVELOPMENT; GROWTH, DEVELOPMENT AND AGING; PREGNANCY; PREGNANCY COMPLICATION;

ANIMALS; BRAIN; BRAIN DISEASES; FEMALE; FETAL DEVELOPMENT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84944390294     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0000000000000236     Document Type: Review

References (74)

1. Volpe JJ. Overview: normal and abnormal human brain development. Ment Retard Dev Disabil Res Rev. 2000;6:1-5.
2. Atladóttir HO, Thorsen P, Østergaard L, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord. 2010;40:1423-1430.
3. Atladóttir HÓ, Henriksen TB, Schendel DE, et al. Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study. Pediatrics. 2012;130:e1447-e1454.
4. Sørensen HJ, Mortensen EL, Reinisch JM, et al. Association between prenatal exposure to bacterial infection and risk of schizophrenia. Schizophr Bull. 2009;35:631-637.
5. Ellman LM, Yolken RH, Buka SL, et al. Cognitive functioning prior to the onset of psychosis: the role of fetal exposure to serologically determined influenza infection. Biol Psychiatry. 2009;65:1040-1047.
6. Parboosing R, Bao Y, Shen L, et al. Gestational influenza and bipolar disorder in adult offspring. JAMA Psychiatry. 2013;70:677-685.
7. Msellati P, Lepage P, Hitimana DG, et al. Neurodevelopmental testing of children born to human immunodeficiency virus type 1 seropositive and seronegative mothers: a prospective cohort study in Kigali, Rwanda. Pediatrics. 1993;92:843-848.
8. Nozyce M, Hittelman J, Muenz L, et al. Effect of perina-tally acquired human immunodeficiency virus infection on neurodevelopment in children during the first two years of life. Pediatrics. 1994;94:883-891.
9. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl JMed. 1994;331:1173-1180.
10. Briand N, Warszawski J, Mandelbrot L, et al.; ANRS-EPF CO1-CO11 Study Group. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era? Clin Infect Dis. 2013;57:903-914.
11. Salemi JL, Whiteman VE, August EM, et al. Maternal hepatitis B and hepatitis C infection and neonatal neurological outcomes. J Viral Hepat. 2014;21:e144-e153.
12. Asano Y, Yoshikawa T, Suga S, et al. Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics. 1993; 92:219-222.
13. Marin M,GurisD,Chaves SS, Schmid S, Seward JF. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56:1-40.
14. Fowler KB, Stagno S, Pass RF, et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med. 1992;326:663-667.
15. Kimberlin DW, Lin CY, Sánchez PJ, et al.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143:16-25.
16. Nigro G, Adler SP, La Torre R, et al.; Congenital Cytomegalovirus Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl JMed. 2005;353:1350-1362.
17. Nigro G, Adler SP, Parruti G, et al. Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy-a case-control study of the outcome in children. J Infect Dis. 2012;205:215-217.
18. Visentin S, Manara R, Milanese L, et al. Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age. Clin Infect Dis. 2012;55:497-503.
19. Revello MG, Lazzarotto T, Guerra B, et al.; CHIP Study Group. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med. 2014;370:1316-1326.
20. Lanari M, Capretti MG, Lazzarotto T. Neuroimaging examination of newborns in vertically acquired infections. J Matern Fetal Neonatal Med. 2011;24(suppl 1):117-119.
21. Anderson JL, Levy PT, Leonard KB, et al. Congenital lymphocytic choriomeningitis virus: when to consider the diagnosis. J Child Neurol. 2014;29:837-842.
22. Ledger WJ. Perinatal infections and fetal/neonatal brain injury. Curr Opin Obstet Gynecol. 2008;20:120-124.
23. Bonecchi R, Bianchi G, Bordignon PP, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (TH1s) and TH2s. J Exp Med. 1998;187:129-134.
24. Sallusto F, Lenig D, Mackay CR, et al. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med. 1998;187:875-883.
25. Meyer U, Nyffeler M, Engler A, et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci. 2006;26:4752-4762.
26. Burd I, Chai J, Gonzalez J, et al. Beyond whitematter damage: fetal neuronal injury in amousemodel of pretermbirth. AmJ Obstet Gynecol. 2009;201:279.e1-279.e8.
27. Hama T, Miyamoto M, Tsukui H, et al. Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats. Neurosci Lett. 1989;104:340-344.
28. Hama T, Kushima Y, Miyamoto M, et al. Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience. 1991;40:445-452.
29. Kushima Y, Hama T, Hatanaka H. Interleukin-6 as a neurotrophic factor for promoting the survival of cultured catecholaminergic neurons in a chemically defined medium from fetal and postnatal rat midbrains. Neurosci Res. 1992;13:267-280.
30. Kushima Y, Hatanaka H. Interleukin-6 and leukemia inhibitory factor promote the survival of acetylcholinesterase-positive neurons in culture from embryonic rat spinal cord. Neurosci Lett. 1992;143:110-114.
31. von Coelln R, Unsicker K, Krieglstein K. Screening of interleukins for survival-promoting effects on cultured mesencephalic dopa-minergic neurons from embryonic rat brain. Brain Res Dev Brain Res. 1995;89:150-154.
32. Clarencon D, Multon E, Galonnier M, et al. Interleukin-6 modulates acetylcholinesterase activity in CNS neurons. In: Quinn DM, Balasurbramanian AS, Doctor BP, et al., eds. Enzymes of the Cholinesterase Family, 1995 Edition. NewYork: Springer;389-390.
33. Schäfer KH, Mestres P, März P, et al. The IL-6/sIL-6R fusion protein hyper-IL-6 promotes neurite outgrowth and neuron survival in cultured enteric neurons. J Interferon Cytokine Res. 1999;19:527-532.
34. Nelson TE, Campbell IL, Gruol DL. Altered physiology of Purkinje neurons in cerebellar slices from transgenic mice with chronic central nervous system expression of interleukin-6. Neuroscience. 1999;89:127-136.
35. Patterson PH. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res. 2009;204:313-321.
36. VargasDL, Nascimbene C, KrishnanC, et al.Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005;57:67-81.
37. Gomez R, Romero R, Ghezzi F, et al. The fetal inflammatory response syndrome. Am J Obstet Gynecol. 1998;179:194-202.
38. Enayati M, Solati J, HosseiniMH, et al.Maternal infection during late pregnancy increases anxiety- and depression-like behaviors with increasing age in male offspring. Brain Res Bull. 2012;87:295-302.
39. Harvey L, Boksa P. A stereological comparison of GAD67 and reelin expression in the hippocampal stratum oriens of offspring from two mouse models of maternal inflammation during pregnancy. Neuropharmacology. 2012;62:1767-1776.
40. Smith SE, Li J, Garbett K, et al.Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci. 2007; 27:10695-10702.
41. Samuelsson AM, Jennische E, Hansson HA, et al. Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning. Am J Physiol Regul Integr Comp Physiol. 2006; 290:R1345-56.
42. Qiu Z,Sweeney DD,Netzeband JG, et al.Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons. J Neurosci. 1998;18:10445-10456.
43. Platel JC, Lacar B, Bordey A. GABA and glutamate signaling: homeostatic control of adult forebrain neurogenesis. J Mol Histol. 2007;38:303-311.
44. Platel JC, Dave KA,Gordon V, et al.NMDA receptors activated by subventricular zone astrocytic glutamate are critical for neuroblast survival prior to entering a synaptic network. Neuron. 2010;65:859-872.
45. Amani M, Samadi H, Doosti MH, et al. Neonatal NMDA receptor blockade alters anxiety- and depression-related behaviors in a sex-dependent manner in mice. Neuropharmacology. 2013; 73:87-97.
46. Nagai A, Nakagawa E, Hatori K, et al. Generation and characterization of immortalized human microglial cell lines: expression of cytokines and chemokines. Neurobiol Dis. 2001;8:1057-1068.
47. Rodriguez JI, Kern JK. Evidence of microglial activation in autism and its possible role in brain underconnectivity. Neuron Glia Biol. 2011;7:205-213.
48. Harris A, Seckl J. Glucocorticoids, prenatal stress and the programming of disease. Horm Behav. 2011;59:279-289.
49. Sloviter RS, Dean E, Neubort S. Electron microscopic analysis of adrenalectomy-induced hippocampal granule cell degeneration in the rat: apoptosis in the adult central nervous system. J Comp Neurol. 1993;330:337-351.
50. Rúa C, Trejo JL, Machín C, et al. Effects of maternal adrenalectomy and glucocorticoid administration on the development of rat hippocampus. J Hirnforsch. 1995;36:473-483.
51. Dahlgren J, Samuelsson AM, Jansson T, et al. Interleukin-6 in the maternal circulation reaches the rat fetus in mid-gestation. Pediatr Res. 2006;60:147-151.
52. Threlkeld SW, Lynch JL, Lynch KM, et al. Ovine proinflammatory cytokines cross themurine blood-brain barrier by a common saturable transport mechanism. Neuroimmunomodulation. 2010;17:405-410.
53. Wyrwoll CS, HolmesMC, Seckl JR. 11β-Hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress. Front Neuroendocrinol. 2011;32:265-286.
54. Girard S, Tremblay L, LepageM, et al. IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inflammation. J Immunol. 2010;184:3997-4005.
55. Meyer U, Murray PJ, Urwyler A, et al. Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated antiinflammatory signaling. Mol Psychiatry. 2008;13:208-221.
56. Brown AS, Hooton J, Schaefer CA, et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry. 2004;161:889-895.
57. Ellman LM, Deicken RF, Vinogradov S, et al. Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8. Schizophr Res. 2010;121:46-54.
58. Gotsch F, Romero R, Kusanovic JP, et al. The fetal inflammatory response syndrome. Clin Obstet Gynecol. 2007;50:652-683.
59. Buka SL, Tsuang MT, Torrey EF, et al. Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun. 2001;15:411-420.
60. Romero R, Avila C, Santhanam U, et al. Amniotic fluid interleukin 6 in preterm labor. Association with infection. J Clin Invest. 1990;85:1392-1400.
61. Romero R, Maymon E, Pacora P, et al. Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor alpha. Am J Obstet Gynecol. 2000;183:1070-1077.
62. Duff P, Sweet RL, Edwards RK. Maternal and Fetal Infections. In: Creasy RK, Resnik R, Iams JD, et al., eds. Creasy and Resnik's Maternal-Fetal Medicine. 6th ed. Philadelphia, PA: Elsevier; 2008: 739-796.
63. Savard A, Lavoie K, Brochu ME, et al. Involvement of neuronal IL-1β in acquired brain lesions in a rat model of neonatal encephalopathy. J Neuroinflammation. 2013;10:110.
64. Leitner K, Al Shammary M, McLane M, et al. IL-1 receptor blockade prevents fetal cortical brain injury but not preterm birth in a mouse model of inflammation-induced preterm birth and perinatal brain injury. Am J Reprod Immunol. 2014;71: 418-426.
65. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA. 1997;278:207-211.
66. Burd I, Bentz AI, Chai J, et al. Inflammation-induced preterm birth alters neuronal morphology in the mouse fetal brain. J Neurosci Res. 2010;88:1872-1881.
67. Wu YW, Colford JMJr. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA. 2000;284:1417-1424.
68. Redline RW, O' RiordanMA. Placental lesions associated with cerebral palsy and neurologic impairment following term birth. Arch Pathol Lab Med. 2000;124:1785-1791.
69. Gibbs RS, Blanco JD, St Clair PJ, et al. Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. J Infect Dis. 1982;145:1-8.
70. Sperling RS, Ramamurthy RS, Gibbs RS. A comparison of intrapartum versus immediate postpartum treatment of intraamniotic infection. Obstet Gynecol. 1987;70:861-865.
71. Gilstrap LC 3rd, Leveno KJ, Cox SM, et al. Intra-partum treatment of acute chorioamnionitis: impact on neonatal sepsis. Am J Obstet Gynecol. 1988;159:579-583.
72. Gibbs RS, Dinsmoor MJ, Newton ER, et al. A randomized trial of intra-partum versus immediate postpartum treatment of women with intra-amniotic infection. Obstet Gynecol. 1988; 72:823-828.
73. Kent A, Lomas F, Hurrion E, et al. Antenatal steroids may reduce adverse neurological outcome following chorioamnionitis: neuro-developmental outcome and chorioamnionitis in premature infants. J Paediatr Child Health. 2005;41:186-190.
74. Jenkins DD, Chang E, Singh I. Neuroprotective interventions: is it too late? J Child Neurol. 2009;24:1212-1219.